The traumatic brain injury therapeutics market size will grow by $551.39 million during 2019-2023. The market's growth momentum will accelerate during the forecast period because of the steady increase in year-over-year growth.
This report provides a detailed analysis of the market by product (anticonvulsants, anti-anxiety agents, anticoagulants, analgesics, and other therapeutics) and geography (the Americas, APAC, and EMEA). Also, the report analyzes the market's competitive landscape and offers information on several market vendors, including Baxter, Fresenius, Johnson & Johnson Services, Novartis, and Pfizer.
Market Overview
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report
Traumatic Brain Injury Therapeutics Market: Key Drivers & Trends
The large number of pipeline drugs and new drug approvals is the major factor driving the global traumatic brain injury therapeutics market growth. Due to the rising prevalence of traumatic brain injury (TBI), the number of drugs under development for its treatment is expanding at a significant rate. Most of the therapeutics that are in the last phases of development and expected to get marketing approval during the forecast period. Furthermore, there are a few drugs in the pipeline that demonstrate a decent efficacy and safety profile. Once these drugs are affirmed, they will expand the number of products in the market, and fuel the traumatic brain injury therapeutics market size growth.
The introduction of cell therapy and biologics is one of the major traumatic brain injury therapeutics market trends. There is no effective TBI treatment to improve neural structural repair and functional recovery of the patient. Many doctors believe cell therapy can be an effective treatment option due to its higher efficacy and target specificity. This is encouraging several companies to develop cell therapy as an independent treatment option for TBI. Some treatment options have already shown positive trial results and are expected to be launched soon. The traumatic brain injury therapeutics market forecast report predicts that fueled by these factors, the market will grow at a CAGR of almost 5% during the forecast period.
Market Competitive Analysis
The traumatic brain injury therapeutics market is highly fragmented. The market is growing exponentially, offering development opportunities to several market players. The competitive landscape, therefore, is intense. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this traumatic brain injury therapeutics industry analysis report will aid clients to identify new growth opportunities and design new growth strategies.
The report offers a complete analysis of various companies including:
- Baxter
- Fresenius
- Johnson & Johnson Services
- Novartis
- Pfizer
Traumatic Brain Injury Therapeutics Market: Segmentation by Geography
- Americas
- APAC
- EMEA
Global traumatic brain injury therapeutics market analysis reveals the Americas will hold the largest traumatic brain injury therapeutics market share until 2023. The APAC region will account for the highest traumatic brain injury therapeutics market growth throughout the forecast period.
Traumatic Brain Injury Therapeutics Market: Segmentation by Product
- Anticonvulsants
- Anti-anxiety agents
- Anticoagulants
- Analgesics
- Other therapeutics
The anticonvulsants segment will lead the traumatic brain injury therapeutics market share during the forecast period. Anticonvulsants will also account for the highest traumatic brain injury therapeutics market growth. Additionally, the report also provides an accurate prediction of the contribution of the various products segments to the growth of the traumatic brain injury therapeutics market size.
Traumatic Brain Injury Therapeutics Market: Key Highlights of the Report for the Forecast Period 2019-2023
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the traumatic brain injury therapeutics market during the next five years
- Precise estimation of the global traumatic brain injury therapeutics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the traumatic brain injury therapeutics industry across the Americas, APAC, and EMEA
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details on the factors that will challenge the growth of traumatic brain injury therapeutics companies
We can help! Our analysts can customize this report to meet your requirements. Get in touch